Navigation Links
Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
Date:11/25/2007


KENILWORTH, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) recently accepted the filing for review of the New Drug Application (NDA) for asenapine, a fast-dissolving, sublingual tablet. Schering-Plough is seeking marketing approval from the FDA for the treatment of schizophrenia and acute mania or mixed episodes associated with Bipolar I Disorder. In accepting the NDA, the FDA indicated that asenapine will receive a standard review.

The clinical trial program thus far has consisted of schizophrenia and bipolar mania trials involving nearly 3,000 patients.

Schering-Plough acquired asenapine through its combination with Organon BioSciences on November 19, 2007.

About Bipolar Disorder

Bipolar Disorder, commonly referred to as manic-depressive disorder, is a chronic, episodic illness characterized by mania (episodes of elevated moods, extreme irritability, and increased energy), depression (overwhelming feelings of sadness, suicidal thoughts), or a combination of both. It affects approximately one to five percent of adults, including more than 10 million adults in the United States and more than four million people in Europe. (1,2,3) The condition can start early in childhood or later in life, the average age of onset is between 15 and 25 years old.(4) Bipolar Disorder is the sixth leading cause of disability in the world.(2) About half of the patients with Bipolar Disorder who recover in response to treatment experience recurrence two years later(5).

About schizophrenia

Schizophrenia is a chronic, disabling brain disorder characterized by hallucinations, delusio
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... BILLERICA, Mass. , July 28, 2015  Insulet ... insulin pump technology with its OmniPod ® Insulin ... has been appointed to Insulet,s Board of Directors. ... of top-tier healthcare experience to the Insulet Board. She ... of the Joslin Diabetes Center, the world,s largest diabetes ...
(Date:7/28/2015)...  Express Scripts Holding Company (Nasdaq: ESRX ) ... Scripts stockholders of $600.1 million, or $0.88 per diluted ... Table 4, were $1.44 for the second quarter. ... across healthcare are validating the need for size and ... "But, what matters most is how that size and ...
(Date:7/28/2015)... MENLO PARK, Calif. , July 28, 2015 ... global medical device company that is providing innovative ... today announced the publication of the SENZA-RCT results ... , the official Journal of the American Society of ... was a ground-breaking study that was the first ...
Breaking Medicine Technology:Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2
... DAYTON, Ohio, Nov. 19 Riverain Medical announced today ... medical imaging distributor Christie Group to offer SoftView Enhanced ... agreement will bring Dayton, Ohio based Riverain Medical,s products ... reputable sales channel. , SoftView Enhanced Chest Imaging increases ...
... , CAMBRIDGE, Mass., Nov. 19 Ligon Discovery, ... find drugs against high-value targets, today announced that it ... Ventures. The company will use the capital to complete ... high-value disease protein targets. With this investment, incTANK Ventures ...
Cached Medicine Technology:Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3
(Date:7/28/2015)... ... July 28, 2015 , ... ... announces the Lost and Found, a breakthrough technological invention. It is a ... for the consumer electronic industry reached a record high of $211.3 billion in ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... co-host “The Soul of Philanthropy Reframed and Exhibited,” a photographic and narrative exploration ... Street, in Denver’s historic Five Points neighborhood. , Denver is one of only ...
(Date:7/28/2015)... ... ... Morristown Medical Center, part of Atlantic Health System, today announced it was the ... nation, to implant the newly approved CoreValve® Evolut® R System from Medtronic. The system ... , The CoreValve® Evolut® R System was approved by the U.S. Food and Drug ...
(Date:7/28/2015)... ... July 28, 2015 , ... Autism ... in 68 children currently affected with the disorder. For these families, identifying and ... to recovery is extremely daunting. That’s where Talk About Curing Autism (TACA), a ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... U.S. President Barack Obama’s visit to Ethiopia to learn more about the impact ... Future Initiative . This initiative focuses on accelerating agricultural development as an engine ...
Breaking Medicine News(10 mins):Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4
... spot inflammation-related enzyme that may be major contributor to ... An enzyme linked to inflammation boosts the risk of ... high cholesterol, a new study suggests. , Researchers think ... lipoprotein-associated phospholipase A2, they may have another weapon to ...
... ... Illness (NAMI), NAMIWalks help raise funds for local programs. , ... (PRWEB) -- May is Mental Health Month. This weekend, Saturday ... NAMIWalks to raise public awareness about facts concerning mental illness and the ...
... Shah ... Talecris to the legislative and executive branches of government in Washington, D.C. ... Research Triangle Park, NC (Vocus) ... Nimish Shah has joined the public affairs department as vice president, federal government relations., , ...
... ... Cortical Concepts Wins ,Wharton Business Plan Competition Michelson Grand Prize with ,Device that ... Private Sales for Co-eds, , ... Philadelphia, PA (PRWEB) April 29, 2010 -- The Wharton ...
... (April 29, 2010) Unchecked, the natural or innate immune ... accelerator on a car. Eventually, it will kill the host ... directed at understanding how this innate immune system is turned ... regulated. That is important because the innate immune system is ...
... ... alcohol regulations to keep them safe, according to a new poll conducted by a bipartisan ... showed that 75% of adults support “the rights of individual states to set their own ... ...
Cached Medicine News:Health News:Watch Your Cholesterol, Your Blood Pressure ... and This Enzyme? 2Health News:NAMIWalks Kicks-off “Mental Health Month”; Fun Events that Support Serious Work 2Health News:Talecris Biotherapeutics Hires Nimish Shah as Vice President, Federal Government Relations 2Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 2Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 3Health News:A single protein regulates 2 immune pathways 2Health News:Survey Finds Broad Support for Alcohol Regulations to Keep the Public Safe 2
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medium....
Large deep curve....
Medicine Products: